CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating expenses:
Selling, general and administrative	$ 3,125	$ 4,649
Research and development	825	5,732
Change in fair value of contingent consideration	(3,488)	63,769
Total operating costs and expenses	462	74,150
Loss from operations	(462)	(74,150)
Other income (loss):
Change in fair value of convertible notes	(1,631)	(87)
Change in fair value of warrants	86,729	(20,903)
Loss on issuance of warrants	(75,644)
Loss on embedded forward purchase agreements and derivative liabilities, net		(22,917)
Other income, net	103	39
Total other income (loss), net	9,557	(43,868)
Income (loss) before taxes	9,095	(118,018)
Net income (loss)	$ 9,095	$ (118,018)
Basic net income (loss) per share (in dollars per share)	$ 2.28	$ (227.87)
Diluted net income (loss) per share (in dollars per share)	$ 2.28	$ (227.87)
Weighted average shares of common stock outstanding used to compute basic net income (loss) per share	3,984,876	517,915
Weighted average shares of common stock outstanding used to compute diluted net income (loss) per share	3,984,876	517,915